MedPath

Nanobio Corporation

Ownership
Private
Employees
-
Market Cap
-
Website

NB-001 Treatment of Recurrent Herpes Labialis

Phase 3
Conditions
Herpes Labialis
Interventions
Drug: Placebo
First Posted Date
2012-09-27
Last Posted Date
2013-06-14
Lead Sponsor
NanoBio Corporation
Target Recruit Count
362
Registration Number
NCT01695187
Locations
🇺🇸

Coastal Carolina Research Center, Mt. Pleasant, South Carolina, United States

🇺🇸

Radiant Research, Inc, Tucson, Arizona, United States

🇺🇸

The Center for Pharmaceutical Research, P.C., Kansas City, Missouri, United States

and more 5 locations

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer

Phase 1
Completed
Conditions
Healthy Adult Volunteers
Interventions
Biological: NB-1008
Biological: Fluzone IN
First Posted Date
2011-05-16
Last Posted Date
2013-03-28
Lead Sponsor
NanoBio Corporation
Target Recruit Count
125
Registration Number
NCT01354379
Locations
🇺🇸

Johnson County Clin-Trials, Lenexa, Kansas, United States

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008

Phase 1
Completed
Conditions
Healthy Adult Volunteers
Interventions
Other: Control
Biological: NB-1008
First Posted Date
2011-04-12
Last Posted Date
2011-04-12
Lead Sponsor
NanoBio Corporation
Target Recruit Count
199
Registration Number
NCT01333462
Locations
🇺🇸

Johnson County Clin-Trials, Lenexa, Kansas, United States

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)

Phase 3
Completed
Conditions
Recurrent Herpes Labialis
Interventions
Drug: Vehicle
First Posted Date
2011-03-29
Last Posted Date
2013-05-23
Lead Sponsor
NanoBio Corporation
Target Recruit Count
847
Registration Number
NCT01324466
Locations
🇺🇸

South Valley Dermatology, West Jordan, Utah, United States

🇺🇸

Radiant Research, Inc., San Antonio, Texas, United States

🇺🇸

Elite Clinical Studies, LLC, Phoenix, Arizona, United States

and more 24 locations

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis

Phase 3
Completed
Conditions
Recurrent Herpes Simplex Labialis
Interventions
First Posted Date
2011-03-23
Last Posted Date
2013-05-23
Lead Sponsor
NanoBio Corporation
Target Recruit Count
907
Registration Number
NCT01321359
Locations
🇺🇸

Westlake Medical Research, Westlake Village, California, United States

🇺🇸

Intermountain Clinical Research, Draper, Utah, United States

🇺🇸

Progressive Medical Research, Port Orange, Florida, United States

and more 27 locations

Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

Phase 2
Completed
Conditions
Onychomycosis
Interventions
Drug: Vehicle control
First Posted Date
2007-03-28
Last Posted Date
2013-05-23
Lead Sponsor
NanoBio Corporation
Target Recruit Count
443
Registration Number
NCT00453271
Locations
🇺🇸

International Dermatology Research, Miami, Florida, United States

🇺🇸

Northwest Clinical Trial, Boise, Idaho, United States

🇨🇦

Lynderm Research, Inc., Markham, Ontario, Canada

and more 21 locations

Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

Phase 2
Completed
Conditions
Herpes Labialis
First Posted Date
2007-03-28
Last Posted Date
2008-05-30
Lead Sponsor
NanoBio Corporation
Target Recruit Count
1000
Registration Number
NCT00453401
Locations
🇺🇸

Okatie Research Center, LLC, Beaufort, South Carolina, United States

🇺🇸

New River Valley Research Institute, Christiansburg, Virginia, United States

🇺🇸

Coastal Carolina Research Center, Mt. Pleasant, South Carolina, United States

and more 25 locations
© Copyright 2025. All Rights Reserved by MedPath